Atlas Trials

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

Clinical trial NCT06954090 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06954090
Sponsor
Steno Diabetes Center Copenhagen
Status
ENROLLING_BY_INVITATION
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 DMType 2 DM /Diabetic NephropathyAlbuminuria
Start date
2025-11-20
Primary completion
2026-11-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.